rHSC-DIPGVax

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerHSC-DIPGVax
Drug Alias Nameneoantigen heat shock protein vaccine(Ann & Robert H Lurie Children's Hospital of Chicago/Children's Hospital of Orange County/Dana-Farber Cancer Institute Inc)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHeat-shock protein stimulants
TargetsHeat-shock protein
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnn & Robert H Lurie Children'S Hospital Of Chicago
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteChildren'S Hospital Of Orange CountyAnn & Robert H Lurie Children'S Hospital Of Chicago
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A